Clinical Relevance and Therapeutic Significance of MicroRNA-133a Expression Profiles and Functions in Malignant Osteosarcoma-Initiating Cells
Tomohiro Fujiwara(Okayama University), Takahiro Ochiya(Unknown), Akihiko Yoshida(Tokyo National Hospital), Hitoshi Ichikawa(National Cancer Research Institute), Akira Kawai(GTx (United States)), Fumitaka Takeshita, Nobuyoshi Kosaka, Tadashi Kondo(National Cancer Research Institute), Yusuke Yoshioka(Tokyo Medical University), Takeshi Katsuda(Tokyo University of Foreign Studies), Ryou‐u Takahashi(Hiroshima University), Keitaro Hagiwara(Toin University of Yokohama), Toshifumi Ozaki(Okayama University), Daisuke Kubota(Memorial Sloan Kettering Cancer Center), Eisuke Kobayashi
Cited by 72
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
|Journal of Biological Chemistry|2013|770
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier
|Nature Communications|2015|706
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
|Nature Communications|2014|595